In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...

The highest-yielding Dividend Aristocrat stocks make sense now as they reside in sectors poised to benefit from a shifting ...

As a new research report from Colliers says, the role of retail pharmacies has changed over time, moving far beyond roles as ...

Online lenders tied to Native American tribes argue that they aren’t subject to state lending laws, but they backed away from ...

The U.S. Federal Trade Commission's merger-busting, antitrust enforcement powers are coming under threat as conservatives ...

The nation’s three largest PBMs – CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx – inflated ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

Antitrust enforcement has increasingly moved its focus away from the consumer and divorced itself from economic analysis. New ...

The federal government is reportedly going after an apartment company with thousands of rental properties in metro Atlanta.

The markups helped the pharmacy-benefit managers reap $7.3 billion from 2017 to 2022, the FTC found.

The suit accuses the company of falsely advertising rental prices by failing to inform renters of numerous mandatory fees.